Virbac announces that it has finalized the acquisition of a majority stake in Globion, an Indian poultry vaccine company.

This transaction should strengthen Virbac's position in animal health in India, by extending Virbac India's existing poultry ranges into the fast-growing avian vaccines segment.

'Globion has developed solid know-how and expertise in the development, manufacture and marketing of live and inactivated vaccines targeting a wide range of avian pathogens' points out Virbac, which recalls that this company employs 120 people with annual sales of around 12 million euros.

Globion is based in Hyderabad, where its industrial and R&D facilities employ around 120 full-time staff and generate annual sales of around 12 million euros.


Copyright (c) 2023 CercleFinance.com. All rights reserved.